Since 1990, the mortality rate from breast cancer has declined in the United States by 24% and similar reductions have been observed in other countries. Mathematical models suggest that both the use of mammography and the availability of adjuvant chemotherapy and tamoxifen as well as contributing to this improvement. Although breast cancer has traditionally been less common in non-industrialized countries, its incidence in these areas is increasing.

In our country according to recent data from the National Registry of Tumors, ranks second in incidence and remember that in the course of a lifetime, one in eight women will be diagnosed with breast cancer.

It is believed that 50% of women diagnosed with breast cancer has identifiable risk factors other than age and gender. Certain hormonal and reproductive factors and lifestyle, diet and environment are related to the risk. In addition to personal or family history of this neoplasm, histories of benign breast disease is another predisposing factor.

Possibility Related Posts:

• The Male Breast Cancer
  Male breast cancer is rare compared with female breast cancer, but if available, about 1% of breast cancers that are diagnosed are male. Because this is usually paid little attention and diagnosed ...
• Individualized Treatment of Cancer: Prognostic Markers
  In recent years we have discovered some tumor markers (substances found in the body when cancer) that fairly reliably augur tumor progression and prognosis. But not all tumors express the same markers...
• Individualized Treatment of Cancer: Differentiated Medicine
  Some markers that are detected in the tumor used to decide the best therapeutic There are no diseases but sick. This statement, valid for any disease, it is even more in the case of cancer. Each tu...
• Physical Activity May Reduce the Risk of Cancer
  physical activity Cancer is a disease that kills more people during the year. Its destructive power is very important and does not distinguish nationality, social background or economic status. The W...
• Medicine for Liver Cancer
  The FDA approved the first time in 30 years, an indication of antitumor Nexavar for treating liver cancer. Also, the drug received approval from European authorities. The FDA approval was based o...